3rd Clinically Validated Digital Therapeutics Summit

Memo

As the world opens up to digital health, now is the time to design, develop and deliver clinically validated digital therapeutics to patients in need. Back for its 3rd year, the Clinically Validated Digital Therapeutics Summit will unite more stakeholders than ever before. Explore newcomers in the world of DTx, showcasing never before shared case studies. This meeting will solely focus on the actionable uses of digital therapeutics to deliver radically improved patient outcomes. URLs:Tickets: https://go.evvnt.com/666220-0?pid=5569Brochure: https://go.evvnt.com/666220-2?pid=5569 Prices:Conference Only (Industry Pricing): USD 1496.0,Conference Only (Solution Provider Pricing): USD 2169.0,Conference Only (Academic Pricing): USD 1189.0 Speakers: Anand Iyer, Chief Strategy Officer, WellDoc, Anil Jina, Chief Medical Officer, Akili Interactive, Acacia Parks, Chief Scientist, Happify, Owen McCarthy, President and CoFounder, MedRhythms, Saeju Jeong, Co-Founder and CEO, Noom, Pavan Choksi, Investment Associate, Arkitekt Ventures, Brigitta Monz, Global Head Measurement Science, Digital Health Technologies, Roche, Mette Dyhrberg, Founder and CEO, Mymee, Laurel Sweeney, Principal, Access Strategies, Lauren Li, Head of Digital Health, Ipsen, Chris Lento, Head of Healthcare Strategic Partnerships, Noom, Mark Yunger, Head of IT, Servier Pharmaceuticals, Theresa Juday, Director, Specialty Innovation, CVS Health, Melinda Decker, Chief Commercial Officer, Mymee, Frank Baitman, Head of Compliance and Strategy for Digital Platforms, Genentech, Joris Van Dam, Head of Digital Therapeutics, Novartis, Kenneth Snow, Medical Director, CVS Health, Andy Molnar, VP, Market Access, Cognoa, Matthias Zenker, Senior Vice President and Head, Business Development DTx, GAIA AG, Jin Lee, Director of Digital Health Product/Commercial Strategy, Astellas Pharma Date and Time: On Wednesday December 02, 2020 at 8:00 am (ends Thursday December 03, 2020 at 5:00 pm)